Tuesday, June 11, 2013

Reminder: CDC MERS-CoV COCA Call Thursday

image

 

# 7384

 

Although I mentioned it a week ago, it is worth the reminder that on Thursday afternoon – June 13th - the CDC will conduct a COCA Call for clinicians on the MERS Coronavirus.

 

COCA (Clinician Outreach Communication Activity) calls – are designed to provide clinicians and others working in the health field with the latest information on health issues. 

 

Recorded materials from earlier COCA calls may be accessed at this link.  For details on the CDC’s  recent H7N9 COCA Call see (CDC: COCA Call On H7N9).

 

Details on how to attend are provided below:

 

 

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Information and Guidance for Clinicians

Continuing Education = No Continuing Education

Date: Thursday, June 13, 2013

Time: 2:00 - 3:00 pm (Eastern Time)

Join by Phone:
Dial: 888-469-1678

Passcode:
3109821

Join by Webinar: https://www.mymeetings.com/nc/join.php?i=PW1088072&p=3109821&t=c

Presenter(s):

 

Susan Gerber, MD
Medical Epidemiologist
Division of Viral Diseases
National Center for Immunization and Respiratory Disease
Centers for Disease Control and Prevention

Overview:

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a newly identified virus that can cause severe acute respiratory illness and death. MERS cases have been linked to the Middle East, and there is documented spread of the virus internationally. So far, no cases of MERS have been reported in the United States. However, clinicians need to remain vigilant. Epidemiologic investigations have demonstrated that this unique virus spreads from person to person during close contact, such as within families and healthcare facilities. Clinicians have a critical role in recognizing and managing suspect cases of MERS. During this COCA call, a CDC subject matter expert will discuss the clinical signs, epidemiology and infection control recommendations for MERS-CoV.

Objectives:

At the conclusion of the session, the participant will be able to accomplish the following:

  • Describe the key components in the surveillance case definition for a patient under investigation for MERS-CoV infection
  • Identify specimens to be obtained and the appropriate laboratory test to diagnose a patient with MERS-CoV infection
  • List infection control measures appropriate for control of MERS-CoV